Samsung Biologics Co Ltd (207940.KS) Diversifiers

Equity · Currency in KRW · Last updated Jun 5, 2026

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates through Contract Development and Manufacturing Organization (CDMO), and Biopharmaceutical Development and Commercialization segments. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and regulatory support services; and quality, biosafety and analytical testing services, as well as manufactures drug substance. In addition, it engages in the development and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.

Looking to balance out your exposure to 207940.KS? The ETFs below have the lowest correlation with 207940.KS — they tend to move on their own, which can help reduce risk when 207940.KS drops. The stock ideas table highlights individual companies that behave independently from 207940.KS.

No Diversifiers Found for 207940.KS

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements 207940.KS

Add 207940.KS to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with 207940.KS